Health Canada authorizes DAYVIGO (lemborexant) for treatment of insomnia
Health Canada authorizes DAYVIGO (lemborexant) for treatment of insomnia — MISSISSAUGA, ON, Feb. 4, 2021 – Eisai Limited, the Canadian subsidiary of Eisai Inc., today announced the Canadian authorization and … Continue reading Health Canada authorizes DAYVIGO (lemborexant) for treatment of insomnia
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
